ERBB2 and breast carcinoma: One goal of this study was to evaluate the anti-tumor effect of anti-CTLA4 in a mouse model that resembled key features of breast cancer in patients, most importantly tolerance to a TAA (Neu) and the presence of Neu-reactive T-cells.